Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 7, 2010, Pages 1755-1765

  Ricciardelli, Carmela ^a,b   Bianco Miotto, Tina ^a   Jindal, Shalini ^a   Dodd, Thomas J ^c   Cohen, Penelope A ^c   Marshall, Villis R ^d   Sutherland, Peter D ^d   Samaratunga, Hemamali ^e   Kench, James G ^f   Dong, Ying ^g   Wang, Hong ^h   Clements, Judith A ^g   Risbridger, Gail P ^h   Sutherland, Robert L ⁱ   Tilley, Wayne D ^a   Horsfall, David J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e AQUESTA Specialised Uropathology   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; COMPLEMENTARY DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROSTATE SPECIFIC ANTIGEN; PROTEIN; PROTEIN KLK2; PROTEIN KLK3; PROTEIN KLK4; RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAPAROSCOPIC SURGERY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RADICAL RETROPUBIC PROSTATECTOMY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY; ROBOTICS; TISSUE MICROARRAY; BIOSYNTHESIS; GENETICS; LABORATORY DIAGNOSIS; LAPAROSCOPY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; ROBOTICS; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 77954508281     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0059     Document Type: Article

References (26)

1. Schroeck FR, Sun L, Freedland SJ, et al. Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy. BJU Int 2008;102:28-32.
2. Lin DW, Coleman IM, Hawley S, et al. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J Clin Oncol 2006;24:3763-70.
3. Schlomm T, Nakel E, Lubke A, et al. Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol 2008;53:333-46.
4. Betsou F, Barnes R, Burke T, et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009;18:1017-25.
5. Zorn KC, Gallina A, Hutterer GC, et al. External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy. J Endourol 2007;21:1345-51.
6. Dash S, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 2002;161:1743-8. (Pubitemid 35265532)
7. Best S, Sawers Y, Fu VX, Almassi N, Huang W, Jarrard DF. Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urol 2007;70:328-32.
8. Ricciardelli C, Choong CS, Buchanan G, et al. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate 2005;63:19-28.
9. Hall RE, Horsfall DJ, Stahl J, et al. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer. Prostate 2004;58:103-8.
10. Lockwood CA, Ricciardelli C, Raymond WA, Seshadri R, McCaul K, Horsfall DJ. A simple index using video image analysis to predict disease outcome in primary breast cancer. Int J Cancer 1999;84:203-8.
11. Sakko AJ, Butler MS, Byers S, et al. Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiol Biomarkers Prev 2008;17:2488-97.
12. Ricciardelli C, Mayne K, Sykes PJ, et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 1998;4:963-71. (Pubitemid 28183398)
13. Risbridger GP, Wang H, Frydenberg M, Cunha G. The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype. Endocrinology 2001;142:2443-50.
14. Taylor RA, Wang H, Wilkinson SE, et al. Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers. Stem Cells 2009;27:3032-42.
15. Balanathan P, Williams ED, Wang H, et al. Elevated level of inhibin-α subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer. Br J Cancer 2009;100:1784-93.
16. Ramsay AJ, Dong Y, Hunt ML, et al. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. J Biol Chem 2008;283:12293-304.
17. Veveris-Lowe TL, Lawrence MG, Collard RL, et al. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer 2005;12:631-43.
18. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 2005;11:8295-303.
19. Gimenez-Bonafe P, Fedoruk MN, Whitmore TG, et al. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate 2004;59:337-49.
20. 2 tension. Proc Natl Acad Sci U S A 1995;92:5510-14.
21. Fox SB, Generali DG, Harris AL. Breast tumour angiogenesis. Breast Cancer Res 2007;9:216-27.
22. Horii K, Suzuki Y, Kondo Y, et al. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol Cancer Res 2007;5:383-91.
23. Park SY, Kim YJ, Gao AC, et al. Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res 2006;66:5121-9.
24. Erbersdobler A, Isbarn H, Steiner I, et al. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study. Urology 2009;74:1169-73.
25. Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007;27:1859-67.
26. Yousef GM. microRNAs: a new frontier in kallikrein research. Biol Chem 2008;389:689-94.